Market Research Future has published a Cooked Research Report on the Global Hydrate Inhibitors Market.
Hydrate Inhibitors Market was valued at USD 180.3 Million in 2018 and is projected to register a CAGR of 7.70% during the forecast period. The advantages of low-dosage hydrate inhibitors (LDHI) such cost-effectiveness due to requirement of less transportation, storage, and maintenance costs; and effective during extended shut-ins and in low volumes are boosting the growth of the global hydrate inhibitors market largely.
Get a Sample of This Report @ https://www.marketresearchfuture.com/sample_request/8794
Market Research Future (MRFR) identifies the following companies as the Key Players in the global carbon nanotubes market: BASF SE (Germany), Schlumberger Limited (US), Halliburton (US), ARKEMA (France), Evonik Industries AG (Germany), Ecolab (US), Huntsman International LLC (US), Ashland (US), Finoric LLC (US), Omni industrial solutions (US), Tetra Technologies, Inc. (US), and Baker Hughes, a GE Company LLC (US).
Key Findings of the Study
The Global Hydrate Inhibitors Market reached USD 180.3 million in 2018 and is projected to reach USD 323.2 million by the end of 2025, at a CAGR of 7.70% during the forecast period.
Based on type, the thermodynamic hydrate inhibitors segment is likely to register a CAGR of around 7.5% during the forecast period.
On the basis of application, the offshore operations segment is likely to exhibit a CAGR of over 7.9% during the review period.
North America accounted for the largest market share in 2018 and was valued at USD 82.6 million.
According to MRFR analysis, the Global Hydrate Inhibitors Market has been segmented based on Type, Application, and Region.
By Type, the global hydrate inhibitors market has been segmented into thermodynamic hydrate inhibitors and low-dosage hydrate inhibitors. Moreover, the thermodynamic hydrate inhibitors segment has been sub-segmented into methanol, monoethylene glycol, and others. Low-dosage hydrate inhibitors segment has been further segmented into kinetic hydrate inhibitors (KHI), anti-agglomerants (AA), and hybrid. The low-dosage hydrate inhibitors segment is likely to witness significant growth of over 8% during the review period due to its growing adoption in the oil & gas industry.
Based on application, the global hydrate inhibitors market has been divided into onshore operation and offshore operations. The offshore operations segment is projected to register a higher CAGR of over 7.9% during the review period on account of the increasing offshore drilling activities across the globe.
Geographically, the global hydrate inhibitors market has been divided into North America, Asia-Pacific, Europe Latin America, and the Middle East & Africa. As per the analysis of MRFR, North America was the dominant regional market, accounting for a leading market share of over 45% in 2018. Moreover, the increasing investments in oil & gas exploration activities in Asia-Pacific, Latin America, and the Middle East & Africa have surged the demand for hydrate inhibitors.
Access Report Details @ https://www.marketresearchfuture.com/reports/hydrate-inhibitors-market-8794